Resources
Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.
Exciting New Leadership for World-Class Growth
New appointments bring bold new ideas to genitourinary research and care.
Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.
Digging into the "why" of racial disparity in kidney cancer outcomes.
How to Perform Device-Free, Free-Handed Transperineal Prostate Biopsy
Fox Chase Cancer Center’s urologic oncology group shares an educational video that provides instruction on how to perform a device-free, free-handed transperineal prostate biopsy.
Fox Chase Offers Ureteral Mitomycin Gel for Low-Grade Upper Tract Urothelial Carcinoma
Jelmyto provides an alternative treatment option for low-grade UTUC and may spare some patients from nephrectomy. A recent study of the treatment showed a 58% complete response rate.
Molecular Profiling Continues to Shape the Future of Cancer Care
Unraveling the genome to reshape cancer care.
New Prognostic Model More Accurately Predicts Kidney Cancer Recurrence and Survival
Researchers at Fox Chase Cancer Center have developed a model that predicts disease recurrence and survival in patients with intermediate- and high-risk localized kidney cancer more accurately than existing prognostic models.
Kutikov Leads International Effort to Optimize Management of Adrenal Masses
Fox Chase’s Alexander Kutikov, MD, FACS, is leading an international effort to create a centralized, streamlined, point-of-care resource for the management of adrenal masses.
Molecular Profiling Named Top Advance of 2021 by ASCO
An American Society of Clinical Oncology (ASCO) collaborative report named the use of molecular profiling the top advance of 2021, but also identified priority areas for future research.
For some men who need a biopsy to test for prostate cancer, Fox Chase Cancer Center now offers an alternative approach that is safer, with significantly lower risks of infection, and potentially higher rate of tumor detection. This new ...
Christine Amoroso Coordinates Treatment-Optimizing, Dedicated Intravesical Clinic
Amoroso is part of the nurse-led dedicated intravesical clinic that helps optimize treatment for patients and workflow for other physicians and nurses.
Urology Team Continues Focus on Improving Kidney Cancer Surgery Outcomes
Two new collaborative publications focus on treatment decisions for patients with renal masses.
Fox Chase Offering Prostate Micro-Ultrasound Technology
Fox Chase Cancer Center is now offering patients a more convenient and effective method of prostate cancer diagnosis—the ExactVu™ micro-ultrasound system.
Fox Chase Genitourinary Cancer Physicians Gain National Recognition
Three members of Fox Chase Cancer Center’s Genitourinary Cancer Program – Elizabeth Plimack, MD, MS; Alexander Kutikov, MD, FACS; and Benjamin Miron, MD -- have gained national recognition for their work advancing the care of patients ...
Clinical Nurse Manager, Rebecca Farrell, MSN, RN, Keeps Calm, Carries On Amidst COVID-19 Pandemic
As patient care adapted to the restrictions of the COVID-19 pandemic, Farrell continued to ensure that patients had access to cutting-edge care.
Two Studies Provide Answers on Best Approach to Bladder Cancer Treatment
Evaluating the current standards of care for cystectomy yielded interesting results on when it is most appropriate.
Genitourinary Malignancies in the Time of COVID-19
The COVID-19 pandemic has precipitated many changes in medical practice. View this symposium, where the Fox Chase Cancer Center genitourinary (GU) oncology team will discuss the impact of the pandemic on GU cancer care as well as the latest ...
Urologic Oncology APP and MD Author Book Chapter on Kidney Cancer
The clinicians in Fox Chase Cancer Center’s Division of Urology and Urologic Oncology are accustomed to providing patients with specialized care and advanced treatment, but they are also dedicated to sharing their experience and educating ...
Experience and Expertise Makes Retroperitoneal Approach an Option for Renal Surgery
Robot-assisted renal surgery using retroperitoneal access requires substantial technical expertise and experience, and the urologic oncology team at Fox Chase Cancer Center is one of few local centers of excellence that offers it as a treatment option.
International Collaborations Help Optimize Partial Nephrectomy Techniques
The urologic oncology team at Fox Chase Cancer Center continues to foster important international relationships in its pursuit of optimal surgical strategies for kidney cancer.
Benjamin T. Ristau, MD, MHA, Randall A. Lee, MD, and Alexander Kutikov, MD, FACS, present a retroperitoneoscopic robot-assisted partial nephrectomy on a morbidly obese patient.
Cancer Prediction Models May Provide False Sense of Reliability for Guiding Care
Over the last decade, dozens of predictive models have been developed to improve on the ability of stage, grade and type to predict recurrence. Unfortunately, many of the prediction models used by clinicians to guide patient care and clinical ...
De-escalating Treatment for Bladder and Prostate Cancers
Treatment approaches for bladder and prostate cancers have undergone rapid evolution in the last few years. Some patients can now safely delay or avoid surgery entirely and preserve their quality of life with positive oncological outcomes. ...
Clinical Connections - Hypofractionation
Using hypofractionation, or hypofractionated radiation therapy, more radiation dose is delivered per treatment, so patients can complete their course of radiation therapy much faster than conventional treatment.